Patients experiencing irregular heartbeats due to atrial fibrillation (AF), the most prevalent heart rhythm disorder, have long been advised to limit or avoid caffeine. Surprisingly, recent studies indicate that moderate coffee consumption might actually lower the chances of AF returning after treatment.
A research team from the University of California, San Francisco, studied 200 adults with persistent atrial fibrillation who were preparing for a procedure aimed at restoring normal heart rhythm. In this study, participants were divided into two groups. One group continued to enjoy at least one cup of caffeinated coffee daily, while the other group was asked to abstain from coffee and any caffeine for six months.
Researchers primarily aimed to see whether AF occurred consistently, using electrocardiogram recordings lasting at least 30 seconds. They also tracked symptom severity and any side effects.
After six months, 47% of the coffee drinkers experienced AF again, while 64% of those who gave up coffee had recurrences. This suggests that consuming coffee might be linked to a 39% lower relative risk of AF returning.
Importantly, there were no notable differences regarding side effects between the two groups, indicating that moderate coffee consumption was generally well tolerated.
The researchers suggest that it’s not necessarily required for patients recovering from atrial fibrillation to avoid coffee, and in some cases, avoiding it could even be counterproductive. The findings were part of a randomized clinical trial named “DECAF” (Does coffee elimination avoid fibrillation?), which has been published in JAMA.
Dr. Gregory Marcus, who was involved in the study, remarked, “We now plan to seriously consider whether caffeinated coffee consumption may actually be a lifestyle factor that helps patients with atrial fibrillation.” He mentioned they were surprised by how significant the protective effect seemed to be.
He also reassured those with AF or concerns about developing it that drinking caffeinated coffee appears to be safe. However, the researchers emphasized that further investigations are necessary to reaffirm these results.
It’s worth mentioning a few limitations of the study, such as only enrolling individuals who had consumed caffeinated coffee regularly in the past five years. Those who do not drink decaf coffee had to be willing to participate in the study, potentially affecting the findings. Moreover, it was an “open label” study, meaning everyone knew which group they were in, which might influence reporting and behavior.
The authors pointed out that their conclusions specifically address regular coffee, not high-caffeine products like energy drinks or supplements. They stressed that the positive results shouldn’t be applied to products that contain high doses of caffeine, particularly because such drinks have sometimes been linked to AF.
In essence, while these findings open up new avenues of thought regarding coffee and heart health, they should be carefully interpreted in the context of regular consumption and not extended to all forms of caffeine.
